Docon sells 9.9% stake in Thyrocare for ₹986 crore
Docon Technologies sold a 9.9% stake in Thyrocare Technologies for ₹986 crore, reducing its holding to 51.02%. The sale involved 1.57 crore shares at prices between ₹624 and ₹631.71, leading to a 3% rise in Thyrocare's share price.
pre-market1 source ↓written by the desknot a recommendation
- in Thyrocare Technologies
- 9.9% stake
- through bulk
- ₹986 crore
- were offloaded
- 1,57,69,696 shares
- prices ranging
- ₹624 to ₹631.71
- holding decreased
- 51.02%
Docon Technologies sold a 9.9% stake in Thyrocare Technologies for ₹986 crore through bulk and block deals. A total of 1,57,69,696 shares were offloaded at prices ranging from ₹624 to ₹631.71. Following this transaction, Docon's holding decreased to 51.02% from 60.92%.
The sale attracted interest from various institutional investors, which may enhance market sentiment around Thyrocare shares, which rose 3% post-announcement.
Not investment advice. For informational purposes only.